IBDEI0RA ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13460,0)
 ;;=283.19^^87^835^15
 ;;^UTILITY(U,$J,358.3,13460,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13460,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,13460,1,5,0)
 ;;=5^Hemolytic Anemia,Microang
 ;;^UTILITY(U,$J,358.3,13460,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,13461,0)
 ;;=285.1^^87^835^16
 ;;^UTILITY(U,$J,358.3,13461,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13461,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,13461,1,5,0)
 ;;=5^Iron Defic Anemia d/t Act Bld Loss
 ;;^UTILITY(U,$J,358.3,13461,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,13462,0)
 ;;=280.0^^87^835^18
 ;;^UTILITY(U,$J,358.3,13462,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13462,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,13462,1,5,0)
 ;;=5^Iron Defic d/t Chronic
 ;;^UTILITY(U,$J,358.3,13462,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,13463,0)
 ;;=280.9^^87^835^17
 ;;^UTILITY(U,$J,358.3,13463,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13463,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,13463,1,5,0)
 ;;=5^Iron Defic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,13463,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,13464,0)
 ;;=284.2^^87^835^19
 ;;^UTILITY(U,$J,358.3,13464,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13464,1,4,0)
 ;;=4^284.2
 ;;^UTILITY(U,$J,358.3,13464,1,5,0)
 ;;=5^Myelophthisic Anemia
 ;;^UTILITY(U,$J,358.3,13464,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,13465,0)
 ;;=281.9^^87^835^20
 ;;^UTILITY(U,$J,358.3,13465,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13465,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,13465,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,13465,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,13466,0)
 ;;=281.0^^87^835^21
 ;;^UTILITY(U,$J,358.3,13466,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13466,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,13466,1,5,0)
 ;;=5^Pernicious Anemia
 ;;^UTILITY(U,$J,358.3,13466,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,13467,0)
 ;;=287.30^^87^835^22
 ;;^UTILITY(U,$J,358.3,13467,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13467,1,4,0)
 ;;=4^287.30
 ;;^UTILITY(U,$J,358.3,13467,1,5,0)
 ;;=5^Primary Thrombocytopenia
 ;;^UTILITY(U,$J,358.3,13467,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,13468,0)
 ;;=287.0^^87^835^23
 ;;^UTILITY(U,$J,358.3,13468,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13468,1,4,0)
 ;;=4^287.0
 ;;^UTILITY(U,$J,358.3,13468,1,5,0)
 ;;=5^Purpura,Vascular
 ;;^UTILITY(U,$J,358.3,13468,2)
 ;;=^101365
 ;;^UTILITY(U,$J,358.3,13469,0)
 ;;=282.60^^87^835^24
 ;;^UTILITY(U,$J,358.3,13469,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13469,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,13469,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,13469,2)
 ;;=^330077
 ;;^UTILITY(U,$J,358.3,13470,0)
 ;;=282.62^^87^835^25
 ;;^UTILITY(U,$J,358.3,13470,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13470,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,13470,1,5,0)
 ;;=5^Sickle-Cell with Crisis
 ;;^UTILITY(U,$J,358.3,13470,2)
 ;;=^330079
 ;;^UTILITY(U,$J,358.3,13471,0)
 ;;=289.51^^87^835^26
 ;;^UTILITY(U,$J,358.3,13471,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13471,1,4,0)
 ;;=4^289.51
 ;;^UTILITY(U,$J,358.3,13471,1,5,0)
 ;;=5^Splenomegaly,Chronic
 ;;^UTILITY(U,$J,358.3,13471,2)
 ;;=^268000
 ;;^UTILITY(U,$J,358.3,13472,0)
 ;;=282.49^^87^835^27
 ;;^UTILITY(U,$J,358.3,13472,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13472,1,4,0)
 ;;=4^282.49
 ;;^UTILITY(U,$J,358.3,13472,1,5,0)
 ;;=5^Thalassemia NEC
 ;;^UTILITY(U,$J,358.3,13472,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,13473,0)
 ;;=287.49^^87^835^28
 ;;^UTILITY(U,$J,358.3,13473,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13473,1,4,0)
 ;;=4^287.49
 ;;^UTILITY(U,$J,358.3,13473,1,5,0)
 ;;=5^Thrombocytosis,Drug Induced
